Qube Research & Technologies LTD Neuro Pace Inc Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Neuro Pace Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 8,833 shares of NPCE stock, worth $65,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,833
Previous 45,218
80.47%
Holding current value
$65,275
Previous $596,000
88.93%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NPCE
# of Institutions
55Shares Held
19.8MCall Options Held
28.3KPut Options Held
300-
Kck Ltd. Tortola, D85.62MShares$41.5 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$25.2 Million0.62% of portfolio
-
Morgan Stanley New York, NY2.47MShares$18.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$18 Million1.86% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$8.46 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $184M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...